{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:42:24Z","timestamp":1760812944855,"version":"build-2065373602"},"reference-count":106,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplant Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.trim.2023.101903","type":"journal-article","created":{"date-parts":[[2023,8,2]],"date-time":"2023-08-02T11:39:38Z","timestamp":1690976378000},"page":"101903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Stem cells in treatment of crohn's disease: Recent advances and future directions"],"prefix":"10.1016","volume":"80","author":[{"given":"Taha Chartab","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimia","family":"Jazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Bolouriyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Soleymanitabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0005","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13062-020-00280-5","article-title":"Pathophysiology of Crohn\u2019s disease inflammation and recurrence","volume":"15","author":"Petagna","year":"2020","journal-title":"Biol. Direct"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41572-020-0156-2","article-title":"Crohn\u2019s disease","volume":"6","author":"Roda","year":"2020","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0015","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.3390\/ijms24021526","article-title":"Pathophysiology of inflammatory bowel disease: innate immune system","volume":"24","author":"Saez","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrgastro.2015.186","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"De Souza","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trim.2023.101903_bb0025","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.845078","article-title":"The molecular mechanisms of intestinal inflammation and fibrosis in Crohn\u2019s disease","volume":"13","author":"Hayashi","year":"2022","journal-title":"Front. Physiol."},{"issue":"12","key":"10.1016\/j.trim.2023.101903_bb0030","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.4049\/jimmunol.1302238","article-title":"Plasma cells in the mucosa of patients with inflammatory bowel disease produce granzyme B and possess cytotoxic activities","volume":"192","author":"Cupi","year":"2014","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.trim.2023.101903_bb0035","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.3390\/ijms23052850","article-title":"Stem cell therapy: from idea to clinical practice","volume":"23","author":"Mousaei Ghasroldasht","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2023.101903_bb0040","first-page":"1","article-title":"Stem cells an overview","author":"Chowdhury","year":"2021","journal-title":"Stem Cells: Biol. Therap."},{"year":"2005","series-title":"Stem Cells: from Bench to Bedside","author":"Bongso","key":"10.1016\/j.trim.2023.101903_bb0045"},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0050","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cell.2008.01.039","article-title":"Stem cells and early lineage development","volume":"132","author":"Rossant","year":"2008","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0055","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"7299","key":"10.1016\/j.trim.2023.101903_bb0060","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nature09229","article-title":"Nuclear reprogramming to a pluripotent state by three approaches","volume":"465","author":"Yamanaka","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.trim.2023.101903_bb0065","first-page":"6","article-title":"Multipotent stem cell and current application","author":"Sobhani","year":"2017","journal-title":"Acta Medica Iran."},{"issue":"6","key":"10.1016\/j.trim.2023.101903_bb0070","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/wsbm.86","article-title":"Hematopoietic stem cell: self-renewal versus differentiation","volume":"2","author":"Seita","year":"2010","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"7219","key":"10.1016\/j.trim.2023.101903_bb0075","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/nature07406","article-title":"Oligopotent stem cells are distributed throughout the mammalian ocular surface","volume":"456","author":"Majo","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.trim.2023.101903_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-019-1165-5","article-title":"Stem cells: past, present, and future","volume":"10","author":"Zakrzewski","year":"2019","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"11","key":"10.1016\/j.trim.2023.101903_bb0090","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0095","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12712","article-title":"Immune modulation by mesenchymal stem cells","volume":"53","author":"Jiang","year":"2020","journal-title":"Cell Prolif."},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0100","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/gut.2009.199687","article-title":"Immunogenicity of anti-TNF antibodies. Has the veil been lifted?","volume":"60","author":"Van Assche","year":"2011","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0105","first-page":"760","article-title":"Loss of response and requirement of infliximab dose intensification in Crohn's disease: a review","volume":"104","author":"Gisbert","year":"2009","journal-title":"Off. J. Am. College Gastroenterol."},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0110","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/ajg.2011.60","article-title":"Loss of response and need for adalimumab dose intensification in Crohn's disease: a systematic review","volume":"106","author":"Billioud","year":"2011","journal-title":"Off. J. Am. College Gastroenterol."},{"key":"10.1016\/j.trim.2023.101903_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119458","article-title":"Therapeutic prospects of MicroRNAs carried by mesenchymal stem cells-derived extracellular vesicles in autoimmune diseases","volume":"277","author":"Liu","year":"2021","journal-title":"Life Sci."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-021-02533-0","article-title":"Stem cell therapy for Crohn\u2019s disease: systematic review and meta-analysis of preclinical and clinical studies","volume":"12","author":"Wang","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.trim.2023.101903_bb0125","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/S0301-472X(02)00820-2","article-title":"Mesenchymal stem cells promote engraftment of human umbilical cord blood\u2013derived CD34+ cells in NOD\/SCID mice","volume":"30","author":"Noort","year":"2002","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/ar2128","article-title":"Cell therapy for autoimmune diseases","volume":"9","author":"Dazzi","year":"2007","journal-title":"Arthritis Res. Therapy"},{"issue":"9","key":"10.1016\/j.trim.2023.101903_bb0135","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.trim.2023.101903_bb0140","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/gut.2008.168534","article-title":"Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis","volume":"58","author":"Gonzalez-Rey","year":"2009","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0145","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/sj.bmt.1703650","article-title":"Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and hurler syndrome (MPS-IH)","volume":"30","author":"Koc","year":"2002","journal-title":"Bone Marrow Transplant."},{"issue":"13","key":"10.1016\/j.trim.2023.101903_bb0150","doi-asserted-by":"crossref","first-page":"8932","DOI":"10.1073\/pnas.132252399","article-title":"Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone","volume":"99","author":"Horwitz","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"9624","key":"10.1016\/j.trim.2023.101903_bb0155","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","article-title":"Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study","volume":"371","author":"Le Blanc","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.trim.2023.101903_bb0160","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","article-title":"A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation","volume":"48","author":"Garc\u00eda-Olmo","year":"2005","journal-title":"Dis. Colon Rectum"},{"issue":"9","key":"10.1016\/j.trim.2023.101903_bb0165","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1517\/14712598.8.9.1417","article-title":"Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn\u2019s disease","volume":"8","author":"Garcia-Olmo","year":"2008","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"21","key":"10.1016\/j.trim.2023.101903_bb0170","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.3390\/cells11213463","article-title":"Hematopoietic stem cell transplantation in refractory Crohn\u2019s disease: should it be considered?","volume":"11","author":"Reider","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0175","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10162","article-title":"Hematopoietic stem cell transplantation\u201450 years of evolution and future perspectives","volume":"5","author":"Henig","year":"2014","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.trim.2023.101903_bb0180","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fimmu.2018.00646","volume":"9","author":"Pockley","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.trim.2023.101903_bb0185","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2005-04-1417","article-title":"How do stem cells find their way home?","volume":"106","author":"Lapidot","year":"2005","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s12015-011-9240-z","article-title":"Hematopoietic stem cell homing to injured tissues","volume":"7","author":"Kavanagh","year":"2011","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.trim.2023.101903_bb0195","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10616-014-9828-7","article-title":"Autologous transplantation of CD34+ bone marrow derived mononuclear cells in management of non-reconstructable critical lower limb ischemia","volume":"68","author":"Ismail","year":"2016","journal-title":"Cytotechnology"},{"issue":"10","key":"10.1016\/j.trim.2023.101903_bb0200","first-page":"3499","article-title":"Immunomodulatory properties of mesenchymal stromal cells","volume":"110","author":"Nauta","year":"2007","journal-title":"Blood, J. Am. Soc. Hematol."},{"key":"10.1016\/j.trim.2023.101903_bb0205","first-page":"462","article-title":"Hematopoietic stem cell transplantation and Crohn\u2019s disease: position paper from the transplantation Committee of the Brazilian Group for the study of inflammatory bowel diseases (GEDIIB)","volume":"59","author":"Ruiz","year":"2022","journal-title":"Arq. Gastroenterol."},{"issue":"29","key":"10.1016\/j.trim.2023.101903_bb0210","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.3748\/wjg.v19.i29.4702","article-title":"Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses","volume":"19","author":"Chen","year":"2013","journal-title":"World J Gastroenterol: WJG"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0215","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/icb.2012.56","article-title":"Mechanisms of mesenchymal stromal cell immunomodulation","volume":"91","author":"English","year":"2013","journal-title":"Immunol. Cell Biol."},{"issue":"12","key":"10.1016\/j.trim.2023.101903_bb0220","doi-asserted-by":"crossref","first-page":"7787","DOI":"10.4049\/jimmunol.0902318","article-title":"Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis","volume":"183","author":"Zhang","year":"2009","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.trim.2023.101903_bb0225","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1634\/stemcells.2005-0531","article-title":"Transplanted embryonic stem cells successfully survive, proliferate, and migrate to damaged regions of the mouse brain","volume":"24","author":"Srivastava","year":"2006","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0230","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/CIRCULATIONAHA.104.527937","article-title":"Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects","volume":"112","author":"Dai","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.trim.2023.101903_bb0235","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1517\/14712598.2010.519333","article-title":"Mesenchymal stem cells: biological properties and clinical applications","volume":"10","author":"Garc\u00eda-G\u00f3mez","year":"2010","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"11","key":"10.1016\/j.trim.2023.101903_bb0240","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/emm.2013.94","article-title":"Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine","volume":"45","author":"Murphy","year":"2013","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0245","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2249.2007.03422.x","article-title":"Interferon-\u03b3 does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells","volume":"149","author":"Ryan","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.trim.2023.101903_bb0250","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.12659\/MSM.914860","article-title":"Mesenchymal stem cells reverse diabetic nephropathy disease via lipoxin A4 by targeting transforming growth factor \u03b2 (TGF-\u03b2)\/smad pathway and pro-inflammatory cytokines","volume":"25","author":"Bai","year":"2019","journal-title":"Med. Sci. Monitor."},{"key":"10.1016\/j.trim.2023.101903_bb0255","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00125-015-3808-0","article-title":"Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients","volume":"59","author":"Favaro","year":"2016","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.trim.2023.101903_bb0260","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.7150\/jca.37932","article-title":"Mesenchymal stem\/stromal cells-derived IL-6 promotes nasopharyngeal carcinoma growth and resistance to cisplatin via upregulating CD73 expression","volume":"11","author":"Zeng","year":"2020","journal-title":"J. Cancer"},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-3083.2010.02491.x","article-title":"New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins","volume":"73","author":"Sioud","year":"2011","journal-title":"Scand. J. Immunol."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0270","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1053\/j.gastro.2015.03.013","article-title":"Mesenchymal stem cells reduce colitis in mice via release of TSG6, independently of their localization to the intestine","volume":"149","author":"Sala","year":"2015","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-015-0122-1","article-title":"Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn\u2019s disease mucosal T cells are largely dependent on indoleamine 2, 3-dioxygenase activity and cell-cell contact","volume":"6","author":"Ciccocioppo","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.trim.2023.101903_bb0280","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1097\/MIB.0b013e318281f5a3","article-title":"Induced and natural regulatory T cells in the development of inflammatory bowel disease","volume":"19","author":"Mayne","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0290","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1582-4934.2007.00041.x","article-title":"In vitro differentiation of human mesenchymal stem cells to epithelial lineage","volume":"11","author":"P\u0103unescu","year":"2007","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.trim.2023.101903_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.952071","article-title":"Mesenchymal stem\/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases","volume":"13","author":"Che","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trim.2023.101903_bb0300","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12015-012-9375-6","article-title":"Mesenchymal stem cells for cardiac therapy: practical challenges and potential mechanisms","volume":"9","author":"Cashman","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0305","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.scr.2013.08.011","article-title":"Transplantation of mesenchymal stem cells for the treatment of liver diseases, is there enough evidence?","volume":"11","author":"Meier","year":"2013","journal-title":"Stem Cell Res."},{"issue":"12","key":"10.1016\/j.trim.2023.101903_bb0310","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1016\/j.biochi.2013.07.013","article-title":"The secretome of mesenchymal stem cells: potential implications for neuroregeneration","volume":"95","author":"Paul","year":"2013","journal-title":"Biochimie"},{"issue":"11","key":"10.1016\/j.trim.2023.101903_bb0315","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3390\/medicina56110563","article-title":"Mesenchymal stromal cell therapy in the management of perianal fistulas in Crohn\u2019s disease: an up-to-date review","volume":"56","author":"Gallo","year":"2020","journal-title":"Medicina"},{"issue":"15","key":"10.1016\/j.trim.2023.101903_bb0320","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.3390\/ijms20153721","article-title":"Secretome of adipose tissue-derived stem cells (ASCs) as a novel trend in chronic non-healing wounds: an overview of experimental in vitro and in vivo studies and methodological variables","volume":"20","author":"Lombardi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.trim.2023.101903_bb0325","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.3390\/ijms19082200","article-title":"Revisiting the advances in isolation, characterization and secretome of adipose-derived stromal\/stem cells","volume":"19","author":"Dubey","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0330","doi-asserted-by":"crossref","first-page":"4581","DOI":"10.3390\/ijms16034581","article-title":"Recent advances in proteomic studies of adipose tissues and adipocytes","volume":"16","author":"Kim","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trim.2023.101903_bb0335","doi-asserted-by":"crossref","DOI":"10.3332\/ecancer.2018.822","article-title":"Adipose tissue stem cells in regenerative medicine","volume":"12","author":"Miana","year":"2018","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13287-020-01975-2","article-title":"Human adipose mesenchymal stem cells modulate myeloid cells toward an anti-inflammatory and reparative phenotype: role of IL-6 and PGE2","volume":"11","author":"Ortiz-Virumbrales","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"03","key":"10.1016\/j.trim.2023.101903_bb0345","doi-asserted-by":"crossref","first-page":"237","DOI":"10.5999\/aps.2016.43.3.237","article-title":"Melatonin protects human adipose-derived stem cells from oxidative stress and cell death","volume":"43","author":"Tan","year":"2016","journal-title":"Arch. Plast. Surg."},{"key":"10.1016\/j.trim.2023.101903_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10561-007-9048-x","article-title":"Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues","volume":"9","author":"Mirabet","year":"2008","journal-title":"Cell Tissue Bank."},{"key":"10.1016\/j.trim.2023.101903_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-018-2871-5","article-title":"Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis","volume":"374","author":"Zheng","year":"2018","journal-title":"Cell Tissue Res."},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0360","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/apt.13864","article-title":"Mesenchymal stromal cell therapy for inflammatory bowel diseases","volume":"45","author":"Gr\u00e9goire","year":"2017","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.trim.2023.101903_bb0365","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"issue":"6","key":"10.1016\/j.trim.2023.101903_bb0370","doi-asserted-by":"crossref","first-page":"455","DOI":"10.5966\/sctm.2012-0184","article-title":"Adipose tissue-derived multipotent stromal cells have a higher immunomodulatory capacity than their bone marrow-derived counterparts","volume":"2","author":"Melief","year":"2013","journal-title":"Stem Cells Transl. Med."},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0375","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ibd.20070","article-title":"Active and passive smoking in childhood is related to the development of inflammatory bowel disease","volume":"13","author":"Mahid","year":"2007","journal-title":"Inflamm. Bowel Dis."},{"issue":"7","key":"10.1016\/j.trim.2023.101903_bb0380","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3390\/cells8070764","article-title":"Mesenchymal stem cells for perianal Crohn\u2019s disease","volume":"8","author":"Carvello","year":"2019","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.trim.2023.101903_bb0385","first-page":"521","article-title":"Perianal fistulas in patients with Crohn\u2019s disease, part 2: surgical, endoscopic, and future therapies","volume":"14","author":"Gold","year":"2018","journal-title":"Gastroenterol. Hepatol. (N Y)"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0390","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s12955-020-01622-7","article-title":"Burden of disease and adaptation to life in patients with Crohn\u2019s perianal fistula: a qualitative exploration","volume":"18","author":"Adegbola","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"issue":"9","key":"10.1016\/j.trim.2023.101903_bb0395","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2036.2004.01917.x","article-title":"Review article: the medical treatment of Crohn\u2019s perianal fistulas","volume":"19","author":"Schwartz","year":"2004","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0400","first-page":"33","article-title":"Management of complex perianal Crohn\u2019s disease, annals of gastroenterology: quarterly publication of the Hellenic society of","volume":"30","author":"Aguilera-Castro","year":"2017","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.trim.2023.101903_bb0405","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1136\/gutjnl-2013-306709","article-title":"A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease","volume":"63","author":"Gecse","year":"2014","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.trim.2023.101903_bb0410","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.asjsur.2021.03.013","article-title":"Surgical options for perianal fistula in patients with Crohn\u2019s disease: a comparison of seton placement, fistulotomy, and stem cell therapy","volume":"44","author":"Park","year":"2021","journal-title":"Asian J. Surg."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0415","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13287-020-02095-7","article-title":"Efficacy of stem cells therapy for Crohn's fistula: a meta-analysis and systematic review","volume":"12","author":"Cao","year":"2021","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0420","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13287-017-0570-x","article-title":"Systematic review with meta-analysis: the efficacy and safety of stem cell therapy for Crohn's disease","volume":"8","author":"Qiu","year":"2017","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.trim.2023.101903_bb0425","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2022.834870","article-title":"Stem cell injection for complex refractory perianal fistulas in Crohn\u2019s disease: a single center initial experience","volume":"9","author":"Colombo","year":"2022","journal-title":"Front. Surg."},{"issue":"5","key":"10.1016\/j.trim.2023.101903_bb0430","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2017.12.020","article-title":"Long-term efficacy and safety of stem cell therapy (Cx601) for complex perianal fistulas in patients with Crohn\u2019s disease","volume":"154","author":"Pan\u00e9s","year":"2018","journal-title":"Gastroenterology"},{"issue":"10051","key":"10.1016\/j.trim.2023.101903_bb0435","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/S0140-6736(16)31203-X","article-title":"Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn\u2019s disease: a phase 3 randomised, double-blind controlled trial","volume":"388","author":"Pan\u00e9s","year":"2016","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.trim.2023.101903_bb0440","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/bjs\/znac078","article-title":"Remestemcel-L allogeneic bone marrow-derived mesenchymal stem cell product to treat medically refractory Crohn\u2019s colitis: preliminary phase IB\/IIA study","volume":"109","author":"Lightner","year":"2022","journal-title":"Br. J. Surg."},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0445","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/DCR.0000000000002579","article-title":"Durable response in patients with refractory Fistulizing perianal Crohn\u2019s disease using autologous mesenchymal stem cells on a dissolvable matrix: results from the phase I stem cell on matrix plug trial","volume":"66","author":"Dozois","year":"2023","journal-title":"Dis. Colon Rectum"},{"issue":"5","key":"10.1016\/j.trim.2023.101903_bb0450","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1097\/DCR.0000000000002325","article-title":"Follow-up study to evaluate the long-term safety and efficacy of Darvadstrocel (mesenchymal stem cell treatment) in patients with perianal fistulizing Crohn\u2019s disease: ADMIRE-CD phase 3 randomized controlled trial","volume":"65","author":"Garcia-Olmo","year":"2022","journal-title":"Dis. Colon Rectum"},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0455","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/ecco-jcc\/jjab154","article-title":"Mesenchymal stem cell injection in Crohn\u2019s disease strictures: a phase I-II clinical study","volume":"16","author":"Vieujean","year":"2022","journal-title":"J. Crohns Colitis."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0460","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/ecco-jcc\/jjz116","article-title":"Long-term evaluation of allogeneic bone marrow-derived mesenchymal stromal cell therapy for Crohn\u2019s disease perianal fistulas","volume":"14","author":"Barnhoorn","year":"2020","journal-title":"J. Crohn\u2019s Colitis"},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0465","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2017.04.001","article-title":"Autologous mesenchymal stem cells, applied in a bioabsorbable matrix, for treatment of perianal fistulas in patients with Crohn's disease","volume":"153","author":"Dietz","year":"2017","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.trim.2023.101903_bb0470","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.5966\/sctm.2015-0356","article-title":"Treatment of Crohn\u2019s-related rectovaginal fistula with allogeneic expanded-adipose derived stem cells: a phase I-IIa clinical trial","volume":"5","author":"Garc\u00eda-Arranz","year":"2016","journal-title":"Stem Cells Transl. Med."},{"issue":"6","key":"10.1016\/j.trim.2023.101903_bb0475","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/codi.15587","article-title":"Allogeneic expanded adipose-derived mesenchymal stem cell therapy for perianal fistulas in Crohn\u2019s disease: a case series","volume":"23","author":"Cabalzar-Wondberg","year":"2021","journal-title":"Color. Dis."},{"issue":"5","key":"10.1016\/j.trim.2023.101903_bb0480","doi-asserted-by":"crossref","first-page":"532","DOI":"10.5966\/sctm.2014-0199","article-title":"Long-term results of adipose-derived stem cell therapy for the treatment of Crohn\u2019s fistula","volume":"4","author":"Cho","year":"2015","journal-title":"Stem Cells Transl. Med."},{"issue":"3","key":"10.1016\/j.trim.2023.101903_bb0485","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00384-012-1581-9","article-title":"Expanded allogeneic adipose-derived stem cells (eASCs) for the treatment of complex perianal fistula in Crohn\u2019s disease: results from a multicenter phase I\/IIa clinical trial","volume":"28","author":"de la Portilla","year":"2013","journal-title":"Int. J. Color. Dis."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0490","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4174\/astr.2021.101.1.58","article-title":"Efficacy and safety of autologous adipose tissue-derived stem cell therapy for children with refractory Crohn\u2019s complex fistula: a phase IV clinical study","volume":"101","author":"Cho","year":"2021","journal-title":"Ann. Surg. Treat. Res."},{"issue":"1","key":"10.1016\/j.trim.2023.101903_bb0495","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/s13287-020-01636-4","article-title":"Autologous adipose-derived stem cells for the treatment of Crohn's fistula-in-ano: an open-label, controlled trial","volume":"11","author":"Zhou","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0500","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2015.06.014","article-title":"Allogeneic bone marrow\u2013derived mesenchymal stromal cells promote healing of refractory perianal fistulas in patients with Crohn\u2019s disease","volume":"149","author":"Molendijk","year":"2015","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.trim.2023.101903_bb0505","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1136\/gut.2010.214841","article-title":"Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease","volume":"60","author":"Ciccocioppo","year":"2011","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.trim.2023.101903_bb0510","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0164269","article-title":"The effect of gender on mesenchymal stem cell (MSC) efficacy in neonatal hyperoxia-induced lung injury","volume":"11","author":"Sammour","year":"2016","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.trim.2023.101903_bb0515","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0271678X17731964","article-title":"Age of donor of human mesenchymal stem cells affects structural and functional recovery after cell therapy following ischaemic stroke","volume":"38","author":"Yamaguchi","year":"2018","journal-title":"J. Cereb. Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.trim.2023.101903_bb0520","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.stemcr.2017.07.014","article-title":"Crohn's disease disturbs the immune properties of human adipose-derived stem cells related to inflammasome activation","volume":"9","author":"Serena","year":"2017","journal-title":"Stem Cell Rep."},{"issue":"2","key":"10.1016\/j.trim.2023.101903_bb0525","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3727\/096368912X656045","article-title":"Autologous adipose tissue-derived stem cells for the treatment of Crohn\u2019s fistula: a phase I clinical study","volume":"22","author":"Cho","year":"2013","journal-title":"Cell Transplant."},{"issue":"7","key":"10.1016\/j.trim.2023.101903_bb0530","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/DCR.0b013e318255364a","article-title":"Autologous expanded adipose-derived stem cells for the treatment of complex cryptoglandular perianal fistulas: a phase III randomized clinical trial (FATT 1: fistula Advanced Therapy Trial 1) and long-term evaluation","volume":"55","author":"Herreros","year":"2012","journal-title":"Dis. Colon Rectum"}],"container-title":["Transplant Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742300120X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096632742300120X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:05:03Z","timestamp":1760810703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096632742300120X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":106,"alternative-id":["S096632742300120X"],"URL":"https:\/\/doi.org\/10.1016\/j.trim.2023.101903","relation":{},"ISSN":["0966-3274"],"issn-type":[{"type":"print","value":"0966-3274"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stem cells in treatment of crohn's disease: Recent advances and future directions","name":"articletitle","label":"Article Title"},{"value":"Transplant Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trim.2023.101903","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101903"}}